Loader

Pathways

PathWhiz ID Pathway Meta Data

PW124088

Pw124088 View Pathway
drug action

Sotalol Mechanism of Action (New)

Homo sapiens
Sotalol is a potassium channel beta blocker used to treat ventricular arrhythmias and to help maintain normal sinus rhythm in atrial fibrillation and flutter. After being taken orally, it is absorbed into the blood through the GI tract and inhibits the beta 1 adrenergic receptor and the potassium voltage gated channel subfamily H member 2 protein on the cell membranes of cardiomyocytes. The beta 1 adrenergic receptor is responsible for Gs signalling and the production of cyclic adenosine monophosphate (cAMP) which activates the L-type calcium channel. The L-type calcium channel is responsible for the influx of calcium from extracellular environment into the cytosol of cardiomyocytes which activates ryanodine receptors to release calcium from the sarcoplasmic reticulum. Calcium is important for the contraction of heart muscle for myosin to and actin to power-stroke so the slower influx of calcium slows down the contractions of the heart lowering the heart rate. The inhibition of potassium voltage gated channel subfamily H member 2 protein inhibits the efflux of potassium out of the cell during the repolarization phase of an action potential. This lengthens the QT interval of the heartbeat as well as prolonging the repolarization phase of action potentials. This regulates the heart rate and slows down any rapid heartrates.

PW176292

Pw176292 View Pathway
metabolic

Sotalol Predicted Metabolism Pathway

Homo sapiens
Metabolites of Sotalol are predicted with biotransformer.

PW146928

Pw146928 View Pathway
drug action

Sotorasib Drug Metabolism Action Pathway

Homo sapiens

PW146753

Pw146753 View Pathway
drug action

Soy isoflavones Drug Metabolism Action Pathway

Homo sapiens

PW130048

Pw130048 View Pathway
metabolic

Soybean Drug Metabolism

Homo sapiens

PW145294

Pw145294 View Pathway
drug action

Sparfloxacin Drug Metabolism Action Pathway

Homo sapiens

PW000356

Pw000356 View Pathway
drug action

Spectinomycin Action Pathway

Homo sapiens
Spectinomycin (also named Togamycin or Trobicin) is an aminocyclitol antibiotic for the treatment of gonorrhea infections such as penicillin-resistant Neisseria gonorrhoeae (experimental studies shows that spectinomycin equips with bacteriostatic effect against most Neisseria gonorrhoeae strains). It is produced from Streptomyces spectabilis, which is a soil microorganism. Spectinomycin reversibly interferes with the interaction between mRNA and the bacterial 30S ribosomal subunit. It is structurally similar to aminoglycosides, but does not cause misreading of mRNA. It is structurally similar to aminoglycosides, but does not cause misreading of mRNA.

PW125964

Pw125964 View Pathway
drug action

Spectinomycin Anti-bacterial Action Pathway

Homo sapiens
Spectinomycin is an aminocyclitol antibiotic used to treat susceptible strains of gram-negative bacteria, Neisseria gonorrhoeae. It is used (as its dihydrochloride pentahydrate) to treat gonorrhea. It is produced by the bacterium Streptomyces spectabilis. Spectinomycin is an inhibitor of protein synthesis in the bacterial cell by binding to the 30S ribosomal subunit. As a result, this agent interferes with the initiation of protein synthesis and with proper protein elongation. This eventually leads to bacterial cell death.

PW132419

Pw132419 View Pathway
metabolic

Spectinomycin Drug Metabolism

Homo sapiens
Spectinomycin is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Spectinomycin passes through the liver and is then excreted from the body mainly through the kidney.

PW145020

Pw145020 View Pathway
drug action

Spectinomycin Drug Metabolism Action Pathway

Homo sapiens